16:15 - 18:00
Wed-S6
Room: Conde de Cantanhede Theatre
Chair/s:
Ana Domingos, Diego V. Bohorquez
A model of full-length RAGE in complex with S100B sheds new light on the signal transduction mechanism
Oral presentation
Kamil Steczkiewicz 1, Alexander Moysa 1, Dorota NiedziaƂek 1, Dietmar Hammerschmid 2, 3, Lilia Zhukova 1, Frank Sobott 3, 4, Michal Dadlez 1
1 Institute of Biochemistry and Biophysics, PAS, Pawinskiego 5a, 02-109 Warsaw, Poland, 2 Department of Chemistry, King's College London, 7 Trinity Street, SE1 1DB London, UK, 3 Department of Chemistry, Biomolecular & Analytical Mass Spectrometry Group, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium, 4 Astbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Woodhouse Lane, LS2 9JT Leeds, UK
The Receptor for Advanced Glycation End-products (RAGE) is an immunoglobulin-type multiligand transmembrane protein expressed in numerous cell types. For instance, RAGE interaction with S100B leads to RAGE upregulation and initialization of a spiral proinflammatory associated with different neural disorders. The main goal of the presented project was to provide a comprehensive understanding of the structure of RAGE-ligand complexes and to explain the molecular mechanism of signal transduction by this receptor. By combining mass spectrometry-based methods, namely hydrogen-deuterium exchange, cross-linking analysis and native MS, available X-ray structural data, molecular dynamics and integrative molecular modelling we present a structural characterization of the hetero-oligomeric complex of the full-length RAGE with S100B. Our results show that RAGE functions as a tetramer exposing an extensive surface formed by V domains with shape and electrostatics charge suited for efficient S100B binding. Furthermore, HDX results demonstrate an allosteric coupling of the distal extracellular V-domains and the transmembrane region, indicating a possible mechanism of signal transmission by RAGE across the membrane. Our model provides an insight into RAGE-ligand interactions, providing a basis for the rational design of the therapeutic modifiers of its activity.
This research was funded by EU CEPT (POIG.02.02.00-14-024/08-00), Foundation of Polish Science TEAM TECH CORE FACILITY/2016- 2/2, National Multidisciplinary Laboratory of Functional Nanomaterials (POIGT.02.02.00-00-025/09-00), National Science Centre, Poland MAESTRO (2014/14/A/NZ1/00306) and OPUS (2018/31/B/ST4/03809), POL-OPENSCREEN (DIR/WK/2018/06) from Ministry of Science and Higher Education, Antwerp University Research Fund for the Concerted Research Actions grant (BOF-GOA 4D protein structure) and Wellcome Trust multi-user equipment grant 208385/Z/17/Z. This research was supported by PLGrid Infrastructure.